Products and Services | Fair | Strasbourg, France
Come and visit the EDQM, and learn more about the 10th Edition of the European Pharmacopoeia, our latest publications and reference standards, what new products will be coming out in the months ahead and how the EDQM has contributed to the fight against COVID-19.
European Pharmacopoeia / Nitrosamines | Webinar | 21 January 2021 | Strasbourg, France
During its 168th Session, the European Pharmacopoeia Commission adopted a new general chapter on the analysis of N-nitrosamine impurities in active substances (2.5.42, previously listed as 2.4.36). The new general chapter proposes three procedures and focuses mainly on the analysis of N-nitrosamine impurities in angiotensin-II-receptor antagonists (sartans) containing a tetrazole group, for which there are five Ph. Eur. monographs (valsartan, losartan potassium, candesartan cilexetil, irbesartan and olmesartan medoxomil), but may also be helpful to establish a control strategy for other active substances or for medicinal products.
Transfusion / Legal Framework | Webinar | 17 February 2021 | Strasbourg, France
From 27 to 29 October 2020, the EDQM/Council of Europe, in collaboration with the European Commission (EC) organised a virtual conference to mark 10 years of their co-operation in the field of blood transfusion. The conference, entitled “Keeping up with reality and quality: A challenge for European Blood Establishments”, shed light on the challenges faced by blood establishments in securing sustainable blood supplies and a resilient blood transfusion sector in Europe.